Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01943539 · ClinicalTrials.gov registry record · NA
Cognitive ADHD Videogame Exploratory Study
A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Akili Interactive Labs.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 2
- Study locations
NCT01943539: Completed NA study of Attention Deficit Hyperactivity Disorder, sponsored by Akili Interactive Labs.
NCT01943539 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by Akili Interactive Labs. The registered enrollment target is 84 participants, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01943539, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by Akili Interactive Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 2
- Study locations
Study Summary
A study in ADHD and neuro-typical children to assess EVO game play over 29 days.
Primary Outcome
EVO employs a perceptual discrimination attention/memory task as well as a continuous visuomotor "driving" task. Subjects were instructed to target a pre-specified stimulus, and ignore all other stimuli while navigating a road-like course. Reaction time was measured as the time between the initial presentation of the pre-specified target and when the subject tapped the tablet screen. Longer reaction times indicated a larger deficit in multitasking.
Conditions Studied
Interventions
- DEVICE Neuro-typical controls and ADHD will receive EVO game play.
Study Locations (2)
Florida
- Florida Clinical Research Center, LLC - Bradenton
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT01943539 record still lists
NCT01943539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Neuro-typical controls and ADHD will receive EVO game play. is the first listed.
NCT01943539 reports a single indexed study location in Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01943539 about?
NCT01943539 is a clinical study titled "Cognitive ADHD Videogame Exploratory Study". A study in ADHD and neuro-typical children to assess EVO game play over 29 days.
What is the current status of trial NCT01943539?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2013-09. Estimated completion is 2015-05.
What conditions does trial NCT01943539 study?
This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.
What interventions are being tested in trial NCT01943539?
The interventions under investigation include: Neuro-typical controls and ADHD will receive EVO game play. (DEVICE).
Who is sponsoring clinical trial NCT01943539?
This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01943539 being conducted?
This trial has 2 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Hyperactivity Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01943539's enrollment target sits among peer trials
84 49th of 102 higher than 54 of 102 other Attention Deficit Hyperactivity Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HOPS Study: A Conceptual Replication
RECRUITING · NA
-
Acute Effects of Exercise in College Students With ADHD
RECRUITING · NA
-
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
RECRUITING · NA
-
ADHD PreSMA Response Inhibition Therapy
RECRUITING · NA
-
Mindfulness Intervention for College Students With ADHD
RECRUITING · NA
-
BUILT Family Lifestyle Program for Children with ADHD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia